Thomas Pisansky
Overview
Explore the profile of Thomas Pisansky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
275
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choo R, Hillman D, Mitchell C, Daniels T, Vargas C, Rwigema J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Nov;
115(5):1085-1094.
PMID: 36427645
Purpose: To evaluate late gastrointestinal (GI) and genitourinary (GU) toxicity of moderately hypofractionated intensity modulated proton therapy (IMPT) targeting the prostate and pelvic lymph nodes. Methods And Materials: A target...
2.
Ma T, Chu F, Sandler H, Feng F, Efstathiou J, Jones C, et al.
Eur Urol
. 2022 Aug;
82(5):487-498.
PMID: 35934601
Context: The prognostic importance of local failure after definitive radiotherapy (RT) in National Comprehensive Cancer Network intermediate- and high-risk prostate cancer (PCa) patients remains unclear. Objective: To evaluate the prognostic...
3.
Choo R, Hillman D, Daniels T, Vargas C, Rwigema J, Corbin K, et al.
Int J Part Ther
. 2021 Nov;
8(2):41-50.
PMID: 34722810
Purpose: To assess acute gastrointestinal (GI) and genitourinary (GU) toxicities of intensity-modulated proton therapy (IMPT) targeting the prostate/seminal vesicles and pelvic lymph nodes for prostate cancer. Materials And Methods: A...
4.
Fagundes M, Chang J, Michalski J, Soffen E, Davis B, Pisansky T
Int J Radiat Oncol Biol Phys
. 2016 Aug;
96(1):241-2.
PMID: 27511861
No abstract available.
5.
Thames H, Kuban D, Levy L, Horwitz E, Kupelian P, Martinez A, et al.
Radiother Oncol
. 2010 Apr;
96(1):6-12.
PMID: 20400191
Purpose: Assess the importance of overall time (OT) and dose for biochemical failure (BF) after external-beam radiotherapy of prostate cancer in a retrospective analysis of a nine-institution database with 4839...
6.
Michalski J, Lawton C, El Naqa I, Ritter M, OMeara E, Seider M, et al.
Int J Radiat Oncol Biol Phys
. 2009 Apr;
76(2):361-8.
PMID: 19394158
Purpose: To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer. Methods And Materials: An RTOG-sponsored meeting was...
7.
Lawton C, DeSilvio M, Lee W, Gomella L, Grignon D, Gillin M, et al.
Int J Radiat Oncol Biol Phys
. 2006 Nov;
67(1):39-47.
PMID: 17084551
Purpose: To evaluate the effectiveness of transrectal ultrasound-guided permanent radioactive (125)I implantation of the prostate for organ-confined adenocarcinoma of the prostate compared with historical data of prostatectomy and external beam...
8.
Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, et al.
Int J Radiat Oncol Biol Phys
. 2005 Jun;
63(3):795-9.
PMID: 15925452
Purpose: To study the use of the year of therapy as an independent predictor of outcomes, serving as a proxy for time-related changes in therapy and tumor factors in the...
9.
Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, et al.
Int J Radiat Oncol Biol Phys
. 2005 Jan;
61(2):415-9.
PMID: 15667961
Purpose: To study the radiation dose-response as determined by Kaplan-Meier prostate-specific antigen (PSA) disease-free survival (PSA-DFS) estimates in patients with stage T1-T2 prostate cancer treated within a 2-year period (1994-1995)....
10.
Kuban D, Thames H, Levy L, Horwitz E, Kupelian P, Martinez A, et al.
Int J Radiat Oncol Biol Phys
. 2005 Jan;
61(2):409-14.
PMID: 15667960
Purpose: To compare long-term outcome using alternative failure definitions after external beam radiation for localized prostate cancer. Methods And Materials: Data from 4839 patients with stage T1b, T1c, and T2...